Background and Aim: Acinetobacter baumannii is one of the most important opportunistic pathogen that is responsible of nosocomial infections, especially in intensive care units (ICUs). The prevalence of antibiotic resistant A. baumannii is increasing in world, and this may cause significant clinical problems. Therefore, this study aimed to evaluate the rate of antibiotic resistance of A. baumannii using meta-analysis.
Materials and Methods: Information for this study obtained by searching on data bases included: Scopus, PubMed, ISI Web of Science, ISC, SID and Google Scholar by independent researchers using standard keyword and without time limit. Then studies containing inclusion criteria were evaluated. The data were analyzed by using random effects model Meta-analysis method and with the software STATA Ver.12.0.
Results and Conclusions: 11 studies were eligible. This studies were analyzed for antibiotics included: cefotaxime, ceftazidime, amikacin, gentamicin, ciprofloxacin and imipenem, based on random effect models. The highest and lowest resistances were found against cefotaxime and imipenem, respectively. This study showed that A. baumannii strain’s have resistance to a wide range of antimicrobial agents. According to the importance of these bacteria in nosocomial infections particularly in intensive care units, it is necessary to apply appropriate strategies to control the spread of this bacteria.
1. Moammadi F, Arabestani MR, Safari M, Roshanaii G, Alikhani MY. Prevalence of class1, 2 and 3 integrons among extensive drug resistance Acinetobacter baumanii strains isolated from intensive care units in Hamadan, west province, Iran. Iran J Med Microbiol 2014;8 (3):8-14. [In Persian]
2. Pan T, Liu X, Xiang S, Ji W. Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection. Exp Ther Med 2016; 11(4):1345-7.
3. Fazeli H, Motallebi-Rad T, Esfahani BN, Solgi H, Nazari F. Prevalence and Antibiotic Resistance Pattern of Acinetobacter Species Isolated from Al-Zahra Hospital in Isfahan, Iran.J Isfahan Med Sch 2013; 31(233):493-501. [In Persian]
4. Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 2005; 25(6):646-54.
5. Afshar Yavari SH, Rota S, Caglar K, Fidan I. Determination of Resistance Pattern Of Isolated Acintobacter baumannii From Intensive Care Units (ICUS) In Gazi Hospital, Ankara. J Urmia Nurs Midwifery Fac 2016; 13(10):912-8. [In Persian]
6. Normohamady Z, Zamanzad B, Shavarzi A, Kiani P. Evaluation antimicrobial resistance of Acinetobacter baumannii isolated from Shahrekord teaching hospitals in 2013. J Shahrekord Univ Med Sci 2015; 16(6):1-8. [In Persian]
7. Jafari S, Najafipour S, Kargar M, Abdollahi A, Mardaneh J, Fasihy Ramandy M, et al. Phenotypical Evaluation of Multi-Drug Resistant Acinetobacter Baumannii. J Fasa Univ Med Sci 2013; 2(4):254-8. [In Persian]
8. Goudarzi H, Hashemi A, Fatemeh F, Noori M, Erfanimanesh S, Yosefi N, et al. Detection of blaDIM, blaAIM, blaGIM, blaNDM and blaVIM Genes among Acinetobacter baumannii strains isolated from hospitalized patients in Tehran hospitals, Iran. Iran J Med Microbiol 2016; 9(4):32-9. [In Persian]
9. Yin XL, Hou TW, Xu SB, Ma CQ, Yao ZY, Li W, et al. Detection of drug resistance-associated genes of multidrug-resistant Acinetobacter baumannii. Microb Drug Resist 2008; 14(2):145-50.
10. Shakibaie MR, Adeli S, Salehi MH. Antibiotic resistance patterns and extended spectrum b-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran. Antimicrob Resist Infect Control 2012; 1(1):1.
11. Dauner DG, May JR, Steele JC. Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center. Eur J Clin Microbiol Infect Dis 2008; 27(11):1021-4.
12. Bakour S, Touati A, Sahli F, Ameur AA, Haouchine D, Rolain JM, et al. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria. Diagn Microbiol Infect Dis 2013; 76(4):529-31.
13. Sadeghi-Fard NK. The amount of drug resistant strains of Acinetobacter baumannii and other Acinetobacter species Isolated from three hospitals in Tehran. J Ilam Univ Med Sci 2006;14(3):29-36. [In Persian] (http://sjimu.medilam.ac.ir/article-1-73-fa.html)
14. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008; 29(11):996-1011.
15. Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, Chung DR, Peck KR, Song JH, etal. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007; 60(5):1163-7.
16. Ghajavand H, Havaei A, Esfahani BN, Fazeli H, Moghim Sh. Frequency of Multi Drug Resistance Acinetobacter baumannii Isolates in Intensive Care Units (ICU) of Isfahan Hospitals, Iran, via Molecular Method and Their Antimicrobial Resistance Patterns. J Isfahan Med Sch 2014; 32(295):1175-85. [In Persian]
17. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008; 8(12):751-62.